STA-4783

DRUG2 trials

Sponsors

Synta Pharmaceuticals Corp.

Conditions

MelanomaSoft Tissue Sarcoma

Phase 1

STA-4783/Paclitaxel or Paclitaxel Alone in Melanoma

CompletedNCT00084214

Synta Pharmaceuticals Corp.Melanoma

Start: 2004-05-31Target: 103Updated: 2014-03-06

Phase 2

A Study of STA-4783 in Combination With Weekly Paclitaxel for Treatment of Patients With Soft Tissue Sarcomas

CompletedNCT00087997

Synta Pharmaceuticals Corp.Soft Tissue Sarcoma

Start: 2004-07-31End: 2005-10-31Target: 80Updated: 2006-06-20